Shares of Target fell Tuesday morning after the company said higher wages put pressure on profits during the holiday quarter. And Amazon shares are at a new record high, thanks to a new $2,000 price target from Monness Crespi.
Plus we speak with the SVP of global brands at Wyndham about the company's plans to spin off its vacation ownership business into a separate public company, as well as a new feature that gets you to unplug.
And Spotify and Dropbox have both filed to go public in recent weeks. We take a look at how the offerings may fare and what precedent they set for the IPO market this year.
Analysts at Baird reiterated their "outperform" rating on Apple stock, with a price target of $200. Kristen Scholer and Tim Stenovec walk you through setting a limit sell order on the TradeStation platform if you want to lock in gains if and when the stock hits that level.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
